Phenyalkylaminoalkyl compounds and pharmaceutical compositions containing them

A method of inhibiting ulceration of the gastrointestinal mucosa of a mammal comprising administering to said mammal an effective ulcer-inhibiting amount of a compound corresponding to the formula I:

• ##STR44## wherein m represents 1-4,
• n represents 2-5,
• R.sup.1 is hydrogen or lower alkyl,
• R.sup.2 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl, and
• R.sup.3 is hydrogen, lower alkyl, lower alkoxy or halogen, or
• R.sup.2 and R.sup.3 are linked to adjacent carbon atoms and together form an alkylenedioxy group with 1-2 carbon atoms,
• R.sup.4 represents a saturated monocyclic or bicyclic terpene hydrocarbon radical with 10 carbon atoms, or a bicyclic hydrocarbon radical with 11 carbon atoms corresponding to the formula a:
• ##STR45## and Z represents oxygen, an N--R.sup.5 group in which R.sup.5 is lower alkyl, or if R.sup.4 is a group of formula a, Z also may be sulfur,
• or a physiologically acceptable acid addition salt thereof.